Cargando…

AI-based quantification of whole-body tumour burden on somatostatin receptor PET/CT

BACKGROUND: Segmenting the whole-body somatostatin receptor-expressing tumour volume (SRETVwb) on positron emission tomography/computed tomography (PET/CT) images is highly time-consuming but has shown value as an independent prognostic factor for survival. An automatic method to measure SRETVwb cou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gålne, Anni, Enqvist, Olof, Sundlöv, Anna, Valind, Kristian, Minarik, David, Trägårdh, Elin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404578/ https://www.ncbi.nlm.nih.gov/pubmed/37544941 http://dx.doi.org/10.1186/s41824-023-00172-7

Ejemplares similares

Relationship between somatostatin receptor expressing tumour volume and health‐related quality of life in patients with metastatic GEP‐NET
por: Ohlsson, Håkan, et al.
Publicado: (2022)

Freely Available, Fully Automated AI-Based Analysis of Primary Tumour and Metastases of Prostate Cancer in Whole-Body [(18)F]-PSMA-1007 PET-CT
por: Trägårdh, Elin, et al.
Publicado: (2022)

Dose-reduced [(18)F]PSMA-1007 PET is feasible for functional imaging of the renal cortex
por: Valind, Kristian, et al.
Publicado: (2021)

AI-based detection of lung lesions in [(18)F]FDG PET-CT from lung cancer patients
por: Borrelli, Pablo, et al.
Publicado: (2021)

[(18)F]PSMA-1007 PET is comparable to [(99m)Tc]Tc-DMSA SPECT for renal cortical imaging
por: Valind, Kristian, et al.
Publicado: (2023)

[(18)F]PSMA‐1007 renal uptake parameters: Reproducibility and relationship to estimated glomerular filtration rate
por: Valind, Kristian, et al.
Publicado: (2022)

Freely available convolutional neural network-based quantification of PET/CT lesions is associated with survival in patients with lung cancer
por: Borrelli, Pablo, et al.
Publicado: (2022)

Automated quantification of PET/CT skeletal tumor burden in prostate cancer using artificial intelligence: The PET index
por: Lindgren Belal, Sarah, et al.
Publicado: (2023)

Auto-segmentations by convolutional neural network in cervical and anorectal cancer with clinical structure sets as the ground truth
por: Sartor, Hanna, et al.
Publicado: (2020)

Deep learning‐based quantification of PET/CT prostate gland uptake: association with overall survival
por: Polymeri, Eirini, et al.
Publicado: (2019)

Head-to-head comparison of a Si-photomultiplier-based and a conventional photomultiplier-based PET-CT system
por: Oddstig, Jenny, et al.
Publicado: (2021)

Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians
por: Trägårdh, Elin, et al.
Publicado: (2022)

Artificial intelligence could alert for focal skeleton/bone marrow uptake in Hodgkin’s lymphoma patients staged with FDG-PET/CT
por: Sadik, May, et al.
Publicado: (2021)

Artificial Intelligence Increases the Agreement among Physicians Classifying Focal Skeleton/Bone Marrow Uptake in Hodgkin’s Lymphoma Patients Staged with [(18)F]FDG PET/CT—a Retrospective Study
por: Sadik, May, et al.
Publicado: (2022)

Optimization of [(18)F]PSMA-1007 PET-CT using regularized reconstruction in patients with prostate cancer
por: Trägårdh, Elin, et al.
Publicado: (2020)

Adding attenuation corrected images in myocardial perfusion imaging reduces the need for a rest study
por: Trägårdh, Elin, et al.
Publicado: (2013)

The use of a proposed updated EARL harmonization of (18)F-FDG PET-CT in patients with lymphoma yields significant differences in Deauville score compared with current EARL recommendations
por: Ly, John, et al.
Publicado: (2019)

Post-reconstruction enhancement of [(18)F]FDG PET images with a convolutional neural network
por: Ly, John, et al.
Publicado: (2021)

Artificial intelligence-aided CT segmentation for body composition analysis: a validation study
por: Borrelli, Pablo, et al.
Publicado: (2021)

PET/CT imaging 2 h after injection of [(18)F]PSMA-1007 can lead to higher staging of prostate cancer than imaging after 1 h
por: Hvittfeldt, Erland, et al.
Publicado: (2023)

Impact of penalizing factor in a block-sequential regularized expectation maximization reconstruction algorithm for (18)F-fluorocholine PET-CT regarding image quality and interpretation
por: Bjöersdorff, Mimmi, et al.
Publicado: (2019)

Nuclear medicine technologists are able to accurately determine when a myocardial perfusion rest study is necessary
por: Trägårdh, Elin, et al.
Publicado: (2012)

Impact of acquisition time and penalizing factor in a block-sequential regularized expectation maximization reconstruction algorithm on a Si-photomultiplier-based PET-CT system for (18)F-FDG
por: Trägårdh, Elin, et al.
Publicado: (2019)

3D skeletal uptake of (18)F sodium fluoride in PET/CT images is associated with overall survival in patients with prostate cancer
por: Lindgren Belal, Sarah, et al.
Publicado: (2017)

RECOMIA—a cloud-based platform for artificial intelligence research in nuclear medicine and radiology
por: Trägårdh, Elin, et al.
Publicado: (2020)

Correction to: 3D skeletal uptake of (18)F sodium fluoride in PET/CT images is associated with overall survival in patients with prostate cancer
por: Belal, Sarah Lindgren, et al.
Publicado: (2019)

Automated artificial intelligence-based analysis of skeletal muscle volume predicts overall survival after cystectomy for urinary bladder cancer
por: Ying, Thomas, et al.
Publicado: (2021)

Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours
por: Hall, G H, et al.
Publicado: (2002)

PET/CT imaging of spinal inflammation and microcalcification in patients with low back pain: A pilot study on the quantification by artificial intelligence‐based segmentation
por: Piri, Reza, et al.
Publicado: (2022)

Comparison between silicon photomultiplier-based and conventional PET/CT in patients with suspected lung cancer—a pilot study
por: Economou Lundeberg, Johan, et al.
Publicado: (2019)

Automated classification of PET‐CT lesions in lung cancer: An independent validation study
por: Borrelli, Pablo, et al.
Publicado: (2022)

Somatostatin receptor PET/CT in restaging of typical and atypical lung carcinoids
por: Prasad, Vikas, et al.
Publicado: (2015)

Improved Personalised Neuroendocrine Tumours’ Diagnosis Predictive Power by New Receptor Somatostatin Image Processing Quantification
por: Stolniceanu, Cati Raluca, et al.
Publicado: (2021)

Role of Somatostatin Signalling in Neuroendocrine Tumours
por: Rogoza, Olesja, et al.
Publicado: (2022)

PET and PET/CT with (68)Gallium-Labeled Somatostatin Analogues in Non GEP-NETs Tumors
por: Sollini, Martina, et al.
Publicado: (2014)

Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance
por: Chan, David LH, et al.
Publicado: (2017)

FDG-PET/CT for lymph node staging prior to radical cystectomy
por: Pihl, Vilhelm, et al.
Publicado: (2023)

Assessing the accuracy of [(18)F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients
por: Ingvar, Jacob, et al.
Publicado: (2022)

Antiproliferative effects of somatostatin analogs in endocrine tumours
por: Zatelli, Maria Chiara
Publicado: (2009)

Detection and quantification of focal uptake in head and neck tumours: (18)F-FDG PET/MR versus PET/CT
por: Varoquaux, Arthur, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5bgg3btcdt6j2h9ovvdd2d489t